Moreover, in diabetic nephropathy models, EGCG’s cardioprotective effects were abolished in Nrf2 knockout mice, highlighting that its protective actions are Nrf2-dependent [163]. This evidence concerns the gene NFE2L2 and diabetic kidney disease.